Perrigo Co. has entered an agreement to acquire CanAm Care, a distributor of diabetes care products.


Perrigo, CanAm Care, diabetes care, Joseph Papa, diabetes care market, Dex4, hypoglycemia products, insulin delivery syringes, pen needles, lancing products, wound care, compression stockings














































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Perrigo to acquire CanAm Care

January 9th, 2012

ALLEGAN, Mich. – Perrigo Co. has entered an agreement to acquire CanAm Care, a distributor of diabetes care products.

Perrigo said Monday that the $36 million cash deal to buy Alpharetta, Ga.-based CanAm includes its Dex4 hypoglycemia products (tabs, liquids and gels), insulin delivery syringes and pen needles, lancing products, wound care and compression stockings.

The store-brand products, Perrigo noted, will compete in a U.S. diabetes health care market opportunity estimated at over $1.5 billion in annual sales.

"This acquisition, alongside the store-brand glucose monitoring meters and strips powered by ONsync launched in 2011 with AgaMatrix, showcases our continued commitment to providing a comprehensive line of quality, affordable health care to the growing diabetes community," Perrigo chairman and chief executive officer Joseph Papa said in a statement. 

Papa added that the Center for Disease Control and Prevention estimates that one in three Americans will develop diabetes during their lifetime.

"Given the strong patient demand for high-quality and value in the overall diabetes care market," he stated, "we are very pleased to have completed this deal with CanAm Care. Perrigo will be the only full-line, store-brand supplier to our retail customers in the over-the-counter diabetes care market with this combined portfolio."

Advertisement